Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose-Volume Analysis of a Phase II Dose-Escalation Study

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 4, 2007, Pages 1100-1109

  Harsolia, Asif ^a   Vargas, Carlos ^a   Yan, Di ^a   Brabbins, Donald ^a   Lockman, David ^a   Liang, Jian ^a   Gustafson, Gary ^a   Vicini, Frank ^a   Martinez, Alvaro ^a   Kestin, Larry L ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

3D conformal radiation; Dose escalation; Dose volume histogram; Prostate cancer; Urinary toxicity

Indexed keywords

BIOLOGICAL ORGANS; DOSIMETERS; MEDICAL IMAGING; MEDICAL PROBLEMS; RADIOTHERAPY; TOXICITY;

3D CONFORMAL RADIATIONS; BLADDER WALL VOLUMES; CHRONIC URINARY TOXICITY; DOSE ESCALATIONS; DOSE VOLUME HISTOGRAMS; PROSTATE CANCER;

ONCOLOGY;

ADULT; AGED; ARTICLE; BLADDER CAPACITY; BLADDER WALL; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FOLLOW UP; HEMATURIA; HUMAN; KIDNEY PAIN; MAJOR CLINICAL STUDY; NEPHROTOXICITY; ORGAN SIZE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RADIATION DOSE; SKIN MANIFESTATION; URETHRA STRICTURE; URINARY FREQUENCY; URINE INCONTINENCE; URINE RETENTION; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED; URETHRAL STRICTURE; URINARY BLADDER; URINARY INCONTINENCE; URINARY RETENTION; URINATION DISORDERS;

EID: 35448987051     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.076     Document Type: Article

References (29)

1. Michalski J., Winter K., Purdy J.A., et al. Toxicity following 3D radiation therapy for prostate cancer on RTOG 9406 dose level V. Int J Radiat Oncol Biol Phys 57 (2003) S151
2. Michalski J.M., Winter K., Purdy J.A., et al. Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406. Semin Radiat Oncol 12 (2002) 75-80
3. Michalski J.M., Winter K., Purdy J.A., et al. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys 56 (2003) 192-198
4. Pollack A., Zagars G.K., Starkschall G., et al. Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys 34 (1996) 555-564
5. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18 (2000) 3904-3911
6. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
7. Pollack A., Hanlon A., Horwitz E.M., et al. Radiation therapy dose escalation for prostate cancer: A rationale for IMRT. World J Urol 21 (2003) 200-208
8. Ryu J.K., Winter K., Michalski J.M., et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys 54 (2002) 1036-1046
9. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
10. Martinez A.A., Yan D., Lockman D., et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1226-1234
11. Yan D., Lockman D., Brabbins D., et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 289-302
12. Vargas C., Martinez A., Kestin L., et al. Dose-volume analysis of predictors for chronic rectal toxicity following treatment of prostate cancer with adaptive high-dose conformal radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1297-1308
13. In: Flemind I.D., Cooper J.S., Henson D.E., et al. (Eds). AJCC cancer staging handbook. 5th ed. (1998), Lippincot Williams and Wilkins, Philadelphia 203
14. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
15. Cox D.R. Regression models and life-tables. J R Stat Soc B 34 (1972) 187-220
16. Schultheiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 3-11
17. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
18. Zelefsky M.J., Cowen D., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85 (1999) 2460-2480
19. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet 353 (1999) 267-272
20. Koper P.C., Stroom J.C., van Putten W.L., et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: A randomized study. Int J Radiat Oncol Biol Phys 43 (1999) 727-734
21. Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: Acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 49 (2001) 705-712
22. Nuyttens J.J., Milito S., Rust P.F., et al. Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol 64 (2002) 209-214
23. Valicenti R.K., Winter K., Cox J.D., et al. RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?. Int J Radiat Oncol Biol Phys 57 (2003) 614-620
24. Karlsdottir A., Johannessen D.C., Muren L.P., et al. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol 71 (2004) 43-53
25. Hoogeman M.S., van Herk M., Yan D., et al. A model to simulate day-to-day variations in rectum shape. Int J Radiat Oncol Biol Phys 54 (2002) 615-625
26. Jackson A. Partial irradiation of the rectum. Semin Radiat Oncol 11 (2001) 215-223
27. Muren L.P., Ekerold R., Kvinnsland Y., et al. On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning. Radiother Oncol 70 (2004) 11-19
28. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
29. Terk M.D., Stock R.G., and Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160 (1998) 1379-1382